glp 1 before pregnancy Discontinuing GLP-1 Receptor Agonist Use Tied to Risk for Adverse Outcomes MedNews GLP-1 Medications, Fertility, and Pregnancy:

Fukunaga, K., Yoshimura, T., Imachi, H., Kobayashi, T., Saheki, T., Sato, S., Saheki, N., Jiang, W., & Murao, K

Specifically, in rodent studies, semaglutide, the active ingredient in GLP-1 medications, have been shown to cause thyroid C-cell tumors at clinically relevant exposures

Predrag Sikiric, Sven Seiwerth, Rudolf Rucman, Domagoj Drmic, Mirjana Stupnisek, Antonio Kokot, Marko Sever, Ivan Zoricic, Zoran Zoricic, Lovorka Batelja, Tihomil Ziger, Kresimir Luetic, Josipa Vlainic, Zarko Rasic, Martina Lovric Bencic

"I accepted it

Why this approval matters Saxenda was the first GLP-1 drug approved to help with weight loss in the U.S., originally approved in December 2014